Technology | Clinical Decision Support | August 21, 2018

HealthMyne QIDS Platform Adds Cancer Screening Module

New module automates patient tracking to achieve better outcomes through earlier diagnosis and treatment

HealthMyne QIDS Platform Adds Cancer Screening Module

August 21, 2018 — HealthMyne announced the release of Quantitative Imaging Decision Support (QIDS) 5 featuring a new, automated Cancer Screening Module. The module is designed for tracking, communicating and reporting on patients who may be at a higher risk for developing cancer.

QIDS 5 debuts dramatic changes to the platform’s Rapid Precise Metrics (RPM) workflow, improving usability and accuracy. The latest version of QIDS provides radiologists, oncologists, pulmonologists and the entire multidisciplinary care team automated features to detect, measure and track cancerous lesions more effectively, improving patient care.

For patients with a high risk of developing lung cancer, screening has been shown to reduce the risk of death by 20 percent. Unfortunately, less than 2 percent of patients eligible are receiving screening, due to internal workflow issues and staffing/time limitations. By automating the tasks of tracking, communicating and reporting on patients, a much larger percentage can receive recommended screening and more cancers will be caught early with better outcomes.

“The HealthMyne Cancer Screening Module goes well beyond other options available in the lung screening space, helping us monitor patients closely so we can get as much done for them as possible with the limited resources we have,” said one nurse navigator who works with a lung cancer screening program that has navigated thousands of patients.

With the efficiency advantages of the new Cancer Screening Module, she believes the time between screening and surgery could be cut by over 75 percent. “One of the things HealthMyne does is interface with the PACS [picture archiving and communication system],” she said, “and it lets you know when the patient’s radiology results are ready. You can see results, schedule next steps and get the patient through the system quickly.”

Lung cancer screening is an especially important area to improve, because while most insurance plans now cover annual screenings for patients age 55-70 who smoke, it is a preventive step that is not yet on the radar for many primary care physicians. Further, many patients do not inquire about screening because they do not want to admit they smoke.

In addition to the new Cancer Screening Module, upgrades to the RPM workflow allow for fast adjustments, so a full 3-D delineation of the lesion and all the quantitative metrics are delivered in seconds. According to HealthMyne CEO Arvind Subramanian, this helps radiologists gain efficiency and confidence in the data they are providing, and the multidisciplinary team benefits from additional volume-based metrics and more consistency in the data they receive.

“The RPM interface is much improved in terms of ease of use and accuracy,” said Jeffrey Kanne, M.D., professor of radiology, chief of thoracic imaging, and vice chair of quality and safety at the University of Wisconsin-Madison. “HealthMyne’s goal is to improve radiologists’ workflow, making things faster for us and allowing us to see quickly if any change is occurring over time due to treatment. The HealthMyne tool automates a lot of what used to require manual work. With this update, they redid the entire tool set for selecting and contouring lesions in the lung. The tool is more accurate, and it’s much easier to link studies to each other without dragging and dropping. You can put images side by side very quickly, take measurements and directly import the findings into a report.”

For more information: www.healthmyne.com

Related Content

Sponsored Content | Videos | Artificial Intelligence | February 21, 2020
In Artificial Intelligence at RSNA 2019, ITN Contributing Editor Greg Freiherr offers an overview of artificial intel
Altamont’s zero-footprint solution, CaptureWare, allows Mach7’s Enterprise Imaging Platform (EIP) to ingest more DICOM and/or non-DICOM data from various sources in a facility
News | PACS | February 20, 2020
February 20, 2020 — Mach7 announced its partnership with Altamont
Sponsored Content | Videos | Enterprise Imaging | February 19, 2020
Bill Lacy, vice president, Medical Informatics at FUJIFILM Medic...
Recognized as the “Pulitzer Prize of the business press,” the Jesse H. Neal Award finalists are selected for exhibiting journalistic enterprise, service to the industry and editorial craftsmanship
News | Radiology Business | February 19, 2020
February 19, 2020 — Connectiv, a division of The Software and Information Industry Association (SIIA), has announced
The Candelis ImageGrid Plus PACS Server is an ultra-high-performance platform that can support high volume healthcare environments of 1,000 plus modalities
News | PACS | February 12, 2020
February 12, 2020 — The Candelis ImageGrid Plus...
An example of artificial intelligence (AI) being developed by Hitachi to automatically review and identify nodules on lung CT scans. This is part of a suite of AI apps Hitachi is developing. This example was being shown as a work in progress at RSNA 2019.

An example of artificial intelligence (AI) being developed by Hitachi to automatically review and identify nodules on lung CT scans. This is part of a suite of AI apps Hitachi is developing. This example was being shown as a work in progress at RSNA 2019. Photo by Dave Fornell.

Feature | Artificial Intelligence | February 07, 2020 | Sanjay Parekh, Ph.D. 
February 7, 2020 – At the 2019 Radiological Society...
Qynapse, a medical technology company, announced that it received U.S. Food and Drug Administration (FDA) 510(k) clearance for its QyScore software
News | Information Technology | February 04, 2020
February 4, 2020 — Qynapse, a medical technology company, anno
Infervision’s deep learning medical imaging platform is helping screen patients for the coronavirus in China. It acts as second pair of eyes to identify multiple diseases from one set of chest scans. The artificial intelligence (AI) can provide a complete view of the nodule, including volume and density.

Infervision’s deep learning medical imaging platform is helping screen patients for the coronavirus in China. It acts as second pair of eyes to identify multiple diseases from one set of chest scans. The artificial intelligence (AI) can provide a complete view of the nodule, including volume and density.

News | Artificial Intelligence | February 04, 2020
February 4, 2020 — Since January 2020, the...